SCHEDULE: Vivo Funds Disclose 9.99% Stake in Clene Inc.

Vivo Opportunity entities have reported beneficial ownership of 9.99% of Clene Inc.'s common stock, primarily through exercisable warrants.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of Clene Inc. securities.
• The reporting persons are Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., and Vivo Opportunity Cayman, LLC.
• These entities collectively hold warrants that, if exercised, would represent 1,321,675 shares of Clene Inc. common stock.
• The total percentage of the class of securities represented by these potential shares is 9.99% for each reporting entity.
• The warrants include Series A Warrants, Series B Warrants, and Tranche B Warrants, with exercise dates in January 2026 and June 2023 respectively.
• All warrants contain provisions that prevent exercise if it would result in the holder exceeding 9.99% of the Issuer's voting securities.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, primarily due to the disclosure of significant warrant holdings that represent potential future dilution, without immediate positive operational news.

Positives

• The reporting entities have disclosed their holdings, providing transparency to the market.
• The warrants are held by entities with clear organizational structures (Delaware and Cayman Islands LPs and LLCs).

Negatives

• The disclosure represents a significant potential dilution of existing shareholders' equity if all warrants are exercised.
• The filing does not provide any information on the operational performance or strategic direction of Clene Inc.

Risks

• Potential for significant dilution of existing shareholders' ownership percentage upon exercise of the disclosed warrants.
• The exercise of warrants is subject to a 9.99% ownership cap, which could limit the ability of these entities to increase their stake further through warrant exercise.
• The filing does not provide context on the financial health or operational status of Clene Inc., leaving the strategic intent behind holding these warrants unclear.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Clene Inc. The future outlook is primarily related to the potential exercise of warrants in January 2026, which is subject to a 9.99% ownership cap.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes. However, the significant percentage held through exercisable warrants suggests a substantial interest, potentially positioning Vivo Opportunity entities as key stakeholders or future influencers in Clene Inc.'s strategic decisions, especially if they approach the 9.99% threshold.

Comparison to Industry Standards

• Schedule 13G filings are standard for institutional investors acquiring more than 5% of a company's stock, indicating a passive investment approach.
• The 9.99% ownership cap is a common feature in warrant agreements to avoid triggering stricter reporting requirements under Schedule 13D and to manage potential control implications.

Stakeholder Impact

• Shareholders: Potential for dilution of ownership percentage and voting power upon exercise of warrants.
• Creditors: No immediate impact indicated, but significant future dilution could affect the company's financial structure.
• Management: May need to consider the influence of significant warrant holders in future strategic decisions.

Next Steps

• Monitoring of Clene Inc.'s stock performance and any future disclosures from Vivo Opportunity entities.
• Observation of whether the warrant exercise caps are approached or become a factor in Clene Inc.'s corporate actions.

Key Dates

Recommendation

The filing indicates a significant potential stake through warrants but provides no operational or financial updates on Clene Inc. itself. The 9.99% cap limits immediate control implications, making it a hold pending further information on the company's performance and the strategic intent behind these holdings.

Keywords

Clene Inc., Schedule 13G, Vivo Opportunity, Warrants, Beneficial Ownership, Dilution, Securities, Investment Fund